Sergio R. T.
- Country
- Spain
- Department
- Hepatology
Research Overview
- Efficacy and Safety Evaluation of Elafibranor in Adult Patients with Primary Biliary Cholangitis: A Phase III Randomized, Double-Blind, Placebo-Controlled Study
- Evaluation of Elafibranor 80 mg on Alkaline Phosphatase Normalization in Adults with Primary Biliary Cholangitis Unresponsive or Intolerant to Ursodeoxycholic Acid
- Efficacy and Safety Evaluation of Volixibat in Treating Cholestatic Pruritus in Primary Biliary Cholangitis: A Randomized, Double-Blind, Placebo-Controlled Trial
Data & Insights
Has run more than one trial at 35 of 109 partner sites.
Specializations
Hepatic Disorders
The investigator specializes in treating chronic liver conditions, with particular emphasis on Primary Biliary Cholangitis (PBC) and Primary Sclerosing Cholangitis (PSC).
- Cholestatic Liver Diseases
- Hepatic Cirrhosis Management
- Biliary System Disorders
Their research activities focus on innovative therapeutic approaches for chronic liver diseases and their complications.
Symptomatic Treatment
Expertise in managing symptoms associated with chronic liver conditions, particularly cholestatic pruritus and related manifestations.
- Pruritus Management
- Quality of Life Improvement
- Symptom Assessment Tools
The investigator explores novel therapeutic options for improving patient comfort and daily functioning.
Therapeutic Innovation
Active involvement in evaluating novel treatments including volixibat and elafibranor for liver disorders.
- Experimental Therapeutics
- Treatment-Resistant Cases
- Long-term Disease Management
Their work encompasses both short-term symptom relief and long-term disease modification strategies.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.